Experiences with golimumab in axial spondyloarthritis

Abstract

Axial spondyloarthritis is a chronic rheumatic disease affecting mostly sacroiliac joints and spine. This review discusses two main clinical trials GO-RAIS and GO-AHEAD proving efficacy of golimumab in patients with radiographic as well as non-radiographic axial spondyloarthritis.

Keywords

• axial spondyloarthritis
• magnetic resonance
• active disease
• reactive protein